Yahoo! News: Weight Loss News |
- Abbott diet drug faces U.S. fight to stay on market (Reuters)
- Obesity costs US 215 billion dollars: study (AFP)
- Obese men less likely to get biopsy after PSA screening (Reuters)
- Mystery of the Overweight: Who, Me? (LiveScience.com)
Abbott diet drug faces U.S. fight to stay on market (Reuters) Posted: 14 Sep 2010 09:07 PM PDT Reuters - Amid a battle to reshape the nearly $400 million obesity drug sector, Abbott Laboratories faces a critical test on Wednesday over whether its controversial diet pill should remain on the U.S. market, despite heart risks. |
Obesity costs US 215 billion dollars: study (AFP) Posted: 14 Sep 2010 12:35 PM PDT |
Obese men less likely to get biopsy after PSA screening (Reuters) Posted: 14 Sep 2010 12:34 PM PDT Reuters - Research has shown that obese men have lower rates of prostate cancer than thinner men, but a new study suggests that this does not reflect an actual lower risk, but a lower rate of early detection through prostate cancer screening. |
Mystery of the Overweight: Who, Me? (LiveScience.com) Posted: 14 Sep 2010 12:05 PM PDT LiveScience.com - Studies have shown that most overweight individuals have a hard time estimating their weight problem. |
You are subscribed to email updates from Yahoo! News: Weight Loss News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment